Atlas Trials

Weight-Based Torsemide Dosing in Subjects With Heart Failure

Clinical trial NCT03187509 · COMPLETED

Trial details

NCT number
NCT03187509
Sponsor
New York City Health and Hospitals Corporation
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure
Start date
2018-04-17
Primary completion
2022-03-14
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.